| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |